Operational Readiness and Pilot Interpretation for Studies of Qualitative Fibrinogen States
Abstract
This methodological article proposes an operational readiness framework for the first feasibility pilot in the qualitative fibrinogen open protocol program. It addresses the transition from a written protocol to a research workflow that a qualified team can execute, monitor, and audit.
The framework links each critical operation to an assigned owner, a controlled procedure, sufficient resources, a verifiable record, and an explicit release decision. Its fibrinogen-specific requirements include timely specimen processing, adequate material recovery, preservation of the candidate molecular state during purification, reagent-activity controls, concentration standardization, and balanced allocation across analytical batches.
The article distinguishes three decisions: institutional permission to begin, operational continuation within the pilot, and scientific justification for proceeding to a transfer experiment. Technical feasibility does not independently establish a biological mechanism.
Key topics include capacity-based scheduling, activity-based budgeting, staff competency assessment, end-to-end workflow rehearsal, incident containment, corrective action, monitoring, audit, and documented suspension and restart authority. Resource planning separates participants, visits, preparations, reaction replicates, controls, and justified repeats, avoiding unsupported cost estimates and double counting.
Three operational appendices provide:
An illustrative responsibility and suspension-authority matrix.
An activity-based resource and material-planning worksheet.
A critical-readiness checklist with a rehearsal and launch record.
GO/MODIFY/NO-GO decisions require evidence appropriate to the next named step. Readiness is not treated as a numerical score in which satisfactory items can compensate for an unresolved critical failure.
No actual recruitment, costs, throughput measurements, or pilot outcomes are reported. The proposed instruments require local adaptation and prospective evaluation. This contribution complements the methodological articles on cohort design, biospecimen traceability, and prespecified analysis by defining the operational evidence needed to begin and sustain an interpretable pilot.
Version 2.0 expands Operational Readiness and Pilot Interpretation for Studies of Qualitative Fibrinogen States by integrating operational preparation with pilot execution, blinded data review, interpretation, and progression decisions.
The framework links critical operations to assigned responsibilities, controlled procedures, resources, traceable records, and release criteria. Fibrinogen-specific requirements include material sufficiency, preservation of candidate molecular features during purification, control of copurified components, reagent activity, concentration standardization, and balanced analytical batches.
This version adds guidance on daily specimen, preparation, and assay disposition; documented handling of deviations and repeat measurements; blinded data-quality review; and preparation of the feasibility report. It distinguishes technical repeatability, repeat purification, within-person biological variation, analytical reproducibility, and independent biological replication.
A central clarification concerns the transition from Study 1 to Study 2. A purified-fibrinogen assay already performed during the pilot does not become a distinct transfer experiment merely through repetition. The subsequent study must specify what a defined recipient system and additional experimental manipulation contribute beyond replication.
Interpretation separates favorable functional findings, sufficiently precise evidence against a predefined relevant difference, inconclusive estimates, and analytical failure. Molecular–functional discordance is retained as an informative result rather than used to redefine the primary hypothesis retrospectively.
Six appendices provide proposed instruments for responsibilities and suspension authority, resource planning, readiness assessment, daily disposition, interpretation, and feasibility reporting. GO/MODIFY/NO-GO decisions identify the specific next step and distinguish operational feasibility from scientific justification.
No original participant data, recruitment outcomes, costs, or pilot performance results are reported. The framework and accompanying instruments remain proposals requiring local adaptation and prospective evaluation.
Related
- Selecting Clinical Populations for Studies of Qualitative Fibrinogen Phenotypes: A proposed framework integrating molecular plausibility analytical feasibility confounding and falsifiability
- Laboratory Automation for Causal Studies of Qualitative Fibrinogen Phenotypes: A proposed framework for workflow selection validation and staged implementation
- A lean-six sigma-ergonomics index for assessing shop-floor operational resilience readiness: Method development and SME demonstration.
- From Preparedness to Documented Operational Readiness: Mapping Public Evidence Across the EU/EEA Health-Security Architecture.
- Ebola preparedness in Sierra Leone during the 2026 Bundibugyo virus emergency: institutional findings and introduction of the Architectural and Operational Readiness Gap (AORG) framework.
BibTeX
@misc{moreira2026operational,
title = {{Operational Readiness and Pilot Interpretation for Studies of Qualitative Fibrinogen States}},
author = {Christiano Gondim Moreira},
howpublished = {Zenodo},
year = {2026},
month = oct,
doi = {10.5281/zenodo.23519363},
url = {https://zenodo.org/records/23519363},
note = {CC BY-SA 4.0},
}
RIS
TY - UNPB
TI - Operational Readiness and Pilot Interpretation for Studies of Qualitative Fibrinogen States
AU - Christiano Gondim Moreira
PY - 2026
DA - 2026/10/20
PB - Zenodo
DO - 10.5281/zenodo.23519363
UR - https://zenodo.org/records/23519363
AB - This methodological article proposes an operational readiness framework for the first feasibility pilot in the qualitative fibrinogen open protocol program. It addresses the transition from a written protocol to a research workflow that a qualified team can execute, monitor, and audit. The framework links each critical operation to an assigned owner, a controlled procedure, sufficient resources, a verifiable record, and an explicit release decision. Its fibrinogen-specific requirements include timely specimen processing, adequate material recovery, preservation of the candidate molecular state during purification, reagent-activity controls, concentration standardization, and balanced allocation across analytical batches. The article distinguishes three decisions: institutional permission to begin, operational continuation within the pilot, and scientific justification for proceeding to a transfer experiment. Technical feasibility does not independently establish a biological mechanism. Key topics include capacity-based scheduling, activity-based budgeting, staff competency assessment, end-to-end workflow rehearsal, incident containment, corrective action, monitoring, audit, and documented suspension and restart authority. Resource planning separates participants, visits, preparations, reaction replicates, controls, and justified repeats, avoiding unsupported cost estimates and double counting. Three operational appendices provide: An illustrative responsibility and suspension-authority matrix. An activity-based resource and material-planning worksheet. A critical-readiness checklist with a rehearsal and launch record. GO/MODIFY/NO-GO decisions require evidence appropriate to the next named step. Readiness is not treated as a numerical score in which satisfactory items can compensate for an unresolved critical failure. No actual recruitment, costs, throughput measurements, or pilot outcomes are reported. The proposed instruments require local adaptation and prospective evaluation. This contribution complements the methodological articles on cohort design, biospecimen traceability, and prespecified analysis by defining the operational evidence needed to begin and sustain an interpretable pilot. Version 2.0 expands Operational Readiness and Pilot Interpretation for Studies of Qualitative Fibrinogen States by integrating operational preparation with pilot execution, blinded data review, interpretation, and progression decisions. The framework links critical operations to assigned responsibilities, controlled procedures, resources, traceable records, and release criteria. Fibrinogen-specific requirements include material sufficiency, preservation of candidate molecular features during purification, control of copurified components, reagent activity, concentration standardization, and balanced analytical batches. This version adds guidance on daily specimen, preparation, and assay disposition; documented handling of deviations and repeat measurements; blinded data-quality review; and preparation of the feasibility report. It distinguishes technical repeatability, repeat purification, within-person biological variation, analytical reproducibility, and independent biological replication. A central clarification concerns the transition from Study 1 to Study 2. A purified-fibrinogen assay already performed during the pilot does not become a distinct transfer experiment merely through repetition. The subsequent study must specify what a defined recipient system and additional experimental manipulation contribute beyond replication. Interpretation separates favorable functional findings, sufficiently precise evidence against a predefined relevant difference, inconclusive estimates, and analytical failure. Molecular–functional discordance is retained as an informative result rather than used to redefine the primary hypothesis retrospectively. Six appendices provide proposed instruments for responsibilities and suspension authority, resource planning, readiness assessment, daily disposition, interpretation, and feasibility reporting. GO/MODIFY/NO-GO decisions identify the specific next step and distinguish operational feasibility from scientific justification. No original participant data, recruitment outcomes, costs, or pilot performance results are reported. The framework and accompanying instruments remain proposals requiring local adaptation and prospective evaluation.
ER -